Uncategorized

by Sophiris Bio News Release

In: Uncategorized

No comments

Poster published in 2009
Samuel Denmeade et al.

PRX302 is a transperineally administered, PSA-activated protoxin that produces symptomatic relief in men with moderate to serve BPH.

Download full publication »